Archive for February, 2013

Nano3D Biosciences Releases 96-well BioAssembler for 3D Cell Culture

Nano3D Biosciences (n3D), a company that specializes in three-dimensional (3D) cell culturing technology for the drug discovery, toxicology and life science research markets, announces the release of…(PRWeb February 12, 2013)Read the full story at…


Industry Executives to Explore the Future of Life Sciences Research…

Knowledgent, a leading industry information consultancy focused on maximizing the value of information to empower clients with actionable business insights, is convening industry executives and…(PRWeb February 12, 2013)Read the full story at http:…


Which Patents Cover the Most Drugs

This is a fun infographic. Rather than asking which drugs have the most patents, this chart shows the patents which cover the most drugs. The patents covering the most drugs are: Patent: 5,605,674 PROAIR+HFA PROVENTIL-HFA QVAR+40 QVAR+80 QNASL ALVESCO ZETONNA XOPENEX+HFA Patent: 5,605,674 NOVOLOG+MIX+50%2F50 NOVOLOG+MIX+70%2F30 NOVOLOG+MIX+70%2F30+FLEXPEN NOVOLOG+MIX+70%2F30+PENFILL NOVOLOG NOVOLOG+FLEXPEN NOVOLOG+INNOLET NOVOLOG+PENFILL Patent: 5,605,674 NOVOLOG+MIX+50%2F50 NOVOLOG+MIX+70%2F30 NOVOLOG+MIX+70%2F30+FLEXPEN NOVOLOG+MIX+70%2F30+PENFILL NOVOLOG […]


Intraocular Lens (IOL) Market Worth $3.8 Billion By 2018 Say New…

“Intraocular Lens (IOL): Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2018” is the new market research report added to ReportsnReports.com store.

(PRWeb February 12, 2013)

Read the full story at http://www.prweb.com/releases/intraocular-lens-iol/market-forecast-2018/prweb10422091.htm


Drug Patent Expirations for Jan 19 2013

If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations

FDA Orange Book archives from 2005 to present

Advertise
here

This newsletter is
a free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents





Drug Patent Expirations for January 19 2013

Tradename Applicant Generic Name Patent
Expiration
IRESSA Astrazeneca gefitinib Jan 19, 2013

*Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details.



DrugPatentWatch
Infographics

Which patents protect the most drugs

Which Patents Cover the Most
Drugs?

More
infographics &raquo





DrugPatentWatch Serves Your Competitive Intelligence
Needs

Subscribers have
access to valuable datasets, including:
  • Patent litigation
  • Clinical trial information
  • International patent families
  • International patent priority and PCT
    information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Drug Master Files
  • Dynamic search capabilities with data
    export
  • More…
See the Database
Preview
and Plan
Comparison
. Contact Us with any
questions.





The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details

DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.


Regenerative Medicine and Stem Cells Market Deals Analysis in New…

“Regenerative medicine and Stem cells Partnering Terms and Agreements” is the new market research report added to ReportsnReports.com store.

(PRWeb February 12, 2013)

Read the full story at http://www.prweb.com/releases/regenerative-medicine-and/stem-cells-deals-analysis/prweb10422074.htm


Rigaku publishes new WDXRF Application: Determination of Metals in…

A new application note from Rigaku describes WDXRF analysis of copper concentrate utilizing an advanced correction technique for the fusion method and featuring the Rigaku ZXS Primus III+…(PRWeb February 12, 2013)Read the full story at http://ww…